Salivary Gland Cancer Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194250 | Category: Medical Devices & Consumables | Pages: 61 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Surgery (removing the cancer in an operation) is a common treatment for salivary gland cancer. A doctor may remove the cancer and some of the healthy tissue around the cancer. In some cases, a lymphadenectomy (surgery in which lymph nodes are removed) will also be done.
This report aims to provide a comprehensive presentation of the global market for Salivary Gland Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Salivary Gland Cancer Treatment. This report contains market size and forecasts of Salivary Gland Cancer Treatment in global, including the following market information:
Global Salivary Gland Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Salivary Gland Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Surgical Removal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Salivary Gland Cancer Treatment include Bristol Myers Squibb, LGM Pharma, LLC, Pfizer, Bedford Laboratories, Baxter, Sanofi-Aventis U.S. LLC, Pierre Fabre, Antares Pharma, Inc and CMS Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Salivary Gland Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Salivary Gland Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Salivary Gland Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
    Surgical Removal
    Radiation Therapy
    Drug Therapy
    Others
Global Salivary Gland Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Salivary Gland Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Clinics
    Outpatient Surgery Center
    Diagnostic Center
    Others
Global Salivary Gland Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Salivary Gland Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Salivary Gland Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Salivary Gland Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bristol Myers Squibb
    LGM Pharma, LLC
    Pfizer
    Bedford Laboratories
    Baxter
    Sanofi-Aventis U.S. LLC
    Pierre Fabre
    Antares Pharma, Inc
    CMS Group
    Sandoz Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Salivary Gland Cancer Treatment, market overview.
Chapter 2: Global Salivary Gland Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Salivary Gland Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Salivary Gland Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Salivary Gland Cancer Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Salivary Gland Cancer Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Salivary Gland Cancer Treatment Overall Market Size
    2.1 Global Salivary Gland Cancer Treatment Market Size: 2022 VS 2029
    2.2 Global Salivary Gland Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Salivary Gland Cancer Treatment Players in Global Market
    3.2 Top Global Salivary Gland Cancer Treatment Companies Ranked by Revenue
    3.3 Global Salivary Gland Cancer Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Salivary Gland Cancer Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Salivary Gland Cancer Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Salivary Gland Cancer Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Salivary Gland Cancer Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Salivary Gland Cancer Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Salivary Gland Cancer Treatment Market Size Markets, 2022 & 2029
        4.1.2 Surgical Removal
        4.1.3 Radiation Therapy
        4.1.4 Drug Therapy
        4.1.5 Others
    4.2 By Type - Global Salivary Gland Cancer Treatment Revenue & Forecasts
        4.2.1 By Type - Global Salivary Gland Cancer Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Salivary Gland Cancer Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Salivary Gland Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Salivary Gland Cancer Treatment Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Outpatient Surgery Center
        5.1.5 Diagnostic Center
        5.1.6 Others
    5.2 By Application - Global Salivary Gland Cancer Treatment Revenue & Forecasts
        5.2.1 By Application - Global Salivary Gland Cancer Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Salivary Gland Cancer Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Salivary Gland Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Salivary Gland Cancer Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Salivary Gland Cancer Treatment Revenue & Forecasts
        6.2.1 By Region - Global Salivary Gland Cancer Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Salivary Gland Cancer Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Salivary Gland Cancer Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Salivary Gland Cancer Treatment Revenue, 2018-2029
        6.3.2 US Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.3.3 Canada Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.3.4 Mexico Salivary Gland Cancer Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Salivary Gland Cancer Treatment Revenue, 2018-2029
        6.4.2 Germany Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.3 France Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.4 U.K. Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.5 Italy Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.6 Russia Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.4.8 Benelux Salivary Gland Cancer Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Salivary Gland Cancer Treatment Revenue, 2018-2029
        6.5.2 China Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.5.3 Japan Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.5.4 South Korea Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.5.6 India Salivary Gland Cancer Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Salivary Gland Cancer Treatment Revenue, 2018-2029
        6.6.2 Brazil Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.6.3 Argentina Salivary Gland Cancer Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Salivary Gland Cancer Treatment Revenue, 2018-2029
        6.7.2 Turkey Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.7.3 Israel Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Salivary Gland Cancer Treatment Market Size, 2018-2029
        6.7.5 UAE Salivary Gland Cancer Treatment Market Size, 2018-2029
7 Salivary Gland Cancer Treatment Companies Profiles
    7.1 Bristol Myers Squibb
        7.1.1 Bristol Myers Squibb Company Summary
        7.1.2 Bristol Myers Squibb Business Overview
        7.1.3 Bristol Myers Squibb Salivary Gland Cancer Treatment Major Product Offerings
        7.1.4 Bristol Myers Squibb Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.1.5 Bristol Myers Squibb Key News & Latest Developments
    7.2 LGM Pharma, LLC
        7.2.1 LGM Pharma, LLC Company Summary
        7.2.2 LGM Pharma, LLC Business Overview
        7.2.3 LGM Pharma, LLC Salivary Gland Cancer Treatment Major Product Offerings
        7.2.4 LGM Pharma, LLC Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.2.5 LGM Pharma, LLC Key News & Latest Developments
    7.3 Pfizer
        7.3.1 Pfizer Company Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Salivary Gland Cancer Treatment Major Product Offerings
        7.3.4 Pfizer Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.3.5 Pfizer Key News & Latest Developments
    7.4 Bedford Laboratories
        7.4.1 Bedford Laboratories Company Summary
        7.4.2 Bedford Laboratories Business Overview
        7.4.3 Bedford Laboratories Salivary Gland Cancer Treatment Major Product Offerings
        7.4.4 Bedford Laboratories Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.4.5 Bedford Laboratories Key News & Latest Developments
    7.5 Baxter
        7.5.1 Baxter Company Summary
        7.5.2 Baxter Business Overview
        7.5.3 Baxter Salivary Gland Cancer Treatment Major Product Offerings
        7.5.4 Baxter Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.5.5 Baxter Key News & Latest Developments
    7.6 Sanofi-Aventis U.S. LLC
        7.6.1 Sanofi-Aventis U.S. LLC Company Summary
        7.6.2 Sanofi-Aventis U.S. LLC Business Overview
        7.6.3 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Major Product Offerings
        7.6.4 Sanofi-Aventis U.S. LLC Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.6.5 Sanofi-Aventis U.S. LLC Key News & Latest Developments
    7.7 Pierre Fabre
        7.7.1 Pierre Fabre Company Summary
        7.7.2 Pierre Fabre Business Overview
        7.7.3 Pierre Fabre Salivary Gland Cancer Treatment Major Product Offerings
        7.7.4 Pierre Fabre Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.7.5 Pierre Fabre Key News & Latest Developments
    7.8 Antares Pharma, Inc
        7.8.1 Antares Pharma, Inc Company Summary
        7.8.2 Antares Pharma, Inc Business Overview
        7.8.3 Antares Pharma, Inc Salivary Gland Cancer Treatment Major Product Offerings
        7.8.4 Antares Pharma, Inc Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.8.5 Antares Pharma, Inc Key News & Latest Developments
    7.9 CMS Group
        7.9.1 CMS Group Company Summary
        7.9.2 CMS Group Business Overview
        7.9.3 CMS Group Salivary Gland Cancer Treatment Major Product Offerings
        7.9.4 CMS Group Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.9.5 CMS Group Key News & Latest Developments
    7.10 Sandoz Inc
        7.10.1 Sandoz Inc Company Summary
        7.10.2 Sandoz Inc Business Overview
        7.10.3 Sandoz Inc Salivary Gland Cancer Treatment Major Product Offerings
        7.10.4 Sandoz Inc Salivary Gland Cancer Treatment Revenue in Global Market (2018-2023)
        7.10.5 Sandoz Inc Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Salivary Gland Cancer Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?